Before you sell to, join or invest in Niche Biopharmaceuticals LLC
MentionFox check on Niche Biopharmaceuticals LLC: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/niche-biopharmaceuticals-llc-form-d-25000001
Check Niche Biopharmaceuticals LLC before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Niche Biopharmaceuticals LLC?
Based on the record MentionFox holds for this company. No flag is not a clearance.
Niche Biopharmaceuticals LLC filed a Form D with the Securities and Exchange Commission on 2025-05-09.
Niche Biopharmaceuticals LLC filed a Form D notice of an exempt securities offering with the SEC on May 9, 2025. The filing reports $100K sold. Its industry group is Pharmaceuticals. It names Dayton Reardan (Executive Officer, Director, Promoter), Daniel Saccani (Manager), Paul Brennan (Manager) (SEC Form D, May 9, 2025).
Is this your company?
Sell to companies like Niche Biopharmaceuticals LLC? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-05-09 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Niche Biopharmaceuticals LLC.
Free to see. No signup.
More on the people and the money behind Niche Biopharmaceuticals LLC, from the filings we hold.
Pharmaceuticals raises filed within 90 days of this one, largest first.
Get an email when Niche Biopharmaceuticals LLC files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Niche Biopharmaceuticals LLC raises, hires or launches. No email unless you switch it on.
Watch Niche Biopharmaceuticals LLC →Get the full cited report on Niche Biopharmaceuticals LLC
What the filing shows about Niche Biopharmaceuticals LLC
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Niche Biopharmaceuticals LLC: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Niche Biopharmaceuticals LLC's address as 22345 Bracketts Road, Shorewood, MN 55331.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Niche Biopharmaceuticals LLC →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Niche Biopharmaceuticals LLC See pricing
Niche Biopharmaceuticals LLC is a registered filer with the SEC (CIK 1846144) and has filed since 2023-02-06. 3 filings are on record, the latest on 2026-05-11.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Niche Biopharmaceuticals LLC's Form D of 2025-05-09 names Dayton Reardan, Daniel Saccani, Paul Brennan and 2 more as its officers, directors or promoters.
Its new offerings report $500K sold across 3 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 155 filings in Pharmaceuticals, totalled by week.
Dayton Reardan is named as Executive Officer and Director and Promoter on the Form D that Niche Biopharmaceuticals LLC filed with the SEC on 9 May 2025, one of 5 people that filing names.
On the filing as: Director.
Daniel Saccani is named as Manager on the Form D that Niche Biopharmaceuticals LLC filed with the SEC on 9 May 2025, one of 5 people that filing names.
On the filing as: Director.
Paul Brennan is named as Manager on the Form D that Niche Biopharmaceuticals LLC filed with the SEC on 9 May 2025, one of 5 people that filing names.
On the filing as: Director.
Patrick Schlievert is named as Manager on the Form D that Niche Biopharmaceuticals LLC filed with the SEC on 9 May 2025, one of 5 people that filing names.
On the filing as: Director.
Robert Klem is named as Manager on the Form D that Niche Biopharmaceuticals LLC filed with the SEC on 9 May 2025, one of 5 people that filing names.
5 people named on the filing — 1 holding an executive role and 4 as directors only.
Named as of the 2025-05-09 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Niche Biopharmaceuticals LLC
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Niche Biopharmaceuticals LLC: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Niche Biopharmaceuticals LLC covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Niche Biopharmaceuticals LLCYou get an alert in MentionFox the next time this company shows up.
If you're behind Niche Biopharmaceuticals LLC: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Niche Biopharmaceuticals LLC. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/niche-biopharmaceuticals-llc-form-d-25000001